Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.44 |
| ▸ | MAPT | P10636 | 3/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.43 |
| ▸ | VCAM1 | P19320 | 1/20 | 0.40 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.40 |
| ▸ | RAB9A | P51151 | 4/20 | 0.39 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.39 |
| ▸ | MEN1 | O00255 | 2/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.39 |
| ▸ | NPC1 | O15118 | 1/20 | 0.37 |
| ▸ | HTT | P42858 | 1/20 | 0.37 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.37 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.36 |
| ▸ | RXRA | P19793 | 1/20 | 0.36 |
| ▸ | RXRB | P28702 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.36 |
| ▸ | APEX1 | P27695 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24361455 | 0.92 | SMN1; SMN2 (0.47) | SMN1; SMN2MAPTL3MBTL1TDP1CYP2C9 | |
| SCHEMBL24360911 | 0.85 | MAPT (0.50) | SMN1; SMN2MAPTL3MBTL1TDP1VCAM1 | |
| SCHEMBL24360921 | 0.76 | MAPT (0.53) | SMN1; SMN2MAPTL3MBTL1TDP1RAB9A | |
| SCHEMBL14218905 | 0.73 | SMN1; SMN2 (0.54) | SMN1; SMN2MAPTL3MBTL1TDP1CYP2C9 | |
| SCHEMBL24361030 | 0.73 | THRB (0.36) | VCAM1ALDH1A1HSD17B10THRB | |
| SCHEMBL12128569 | 0.72 | L3MBTL1 (0.44) | MAPTL3MBTL1TDP1NPSR1MEN1 | |
| SCHEMBL28314714 | 0.71 | SMN1; SMN2 (0.57) | SMN1; SMN2MAPTL3MBTL1TDP1RAB9A | |
| SCHEMBL27595513 | 0.71 | MAPT (0.53) | SMN1; SMN2MAPTL3MBTL1TDP1CYP2C9 | |
| SCHEMBL10625899 | 0.71 | SMN1; SMN2 (0.66) | SMN1; SMN2MAPTL3MBTL1TDP1RAB9A | |
| SCHEMBL1205813 | 0.70 | MAPT (0.56) | SMN1; SMN2MAPTL3MBTL1TDP1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220127225-A1 | ONIUM SALT, CHEMICALLY AMPLIFIED RESIST COMPOSITION AND PATTERNING PROCESS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2022-04-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220127225-A1 | ONIUM SALT, CHEMICALLY AMPLIFIED RESIST COMPOSITION AND PATTERNING PROCESS | CACNA1F, SLC6A5, IDUA | SMN1; SMN2 4041/4885MAPT 2279/4885L3MBTL1 3555/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.